@article{Chirehwa2023,
abstract = {Moxifloxacin is included in some treatment regimens for drug-sensitive tuberculosis (TB) and multidrug-resistant TB (MDR-TB). Aiming to optimize dosing, we described moxifloxacin pharmacokinetic an...},
author = {Chirehwa, M T and Resendiz-Galvan, J E and Court, R and {De Kock}, M and Wiesner, L and de Vries, N and Harding, J and Gumbo, T and Warren, R and Maartens, G and Denti, P and McIlleron, H},
doi = {10.1128/AAC.01426-22},
issn = {0066-4804},
journal = {Antimicrobial Agents and Chemotherapy},
keywords = {MDR-TB,efavirenz,moxifloxacin,multidrug resistance,original,pharmacometrics,population pharmacokinetics},
mendeley-tags = {original},
month = {feb},
pages = {10.1128/aac.01426--22},
pmid = {36744891},
publisher = {American Society for Microbiology 1752 N St., N.W., Washington, DC},
title = {{Optimizing moxifloxacin dose in MDR-TB participants with or without efavirenz coadministration using population pharmacokinetic modeling}},
url = {https://journals.asm.org/doi/10.1128/aac.01426-22},
year = {2023}
}

{"_id":"pabkmTqhCsMcN7G4D","bibbaseid":"chirehwa-resendizgalvan-court-dekock-wiesner-devries-harding-gumbo-etal-optimizingmoxifloxacindoseinmdrtbparticipantswithorwithoutefavirenzcoadministrationusingpopulationpharmacokineticmodeling-2023","author_short":["Chirehwa, M T","Resendiz-Galvan, J E","Court, R","De Kock, M","Wiesner, L","de Vries, N","Harding, J","Gumbo, T","Warren, R","Maartens, G","Denti, P","McIlleron, H"],"bibdata":{"bibtype":"article","type":"article","abstract":"Moxifloxacin is included in some treatment regimens for drug-sensitive tuberculosis (TB) and multidrug-resistant TB (MDR-TB). Aiming to optimize dosing, we described moxifloxacin pharmacokinetic an...","author":[{"propositions":[],"lastnames":["Chirehwa"],"firstnames":["M","T"],"suffixes":[]},{"propositions":[],"lastnames":["Resendiz-Galvan"],"firstnames":["J","E"],"suffixes":[]},{"propositions":[],"lastnames":["Court"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["De Kock"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Wiesner"],"firstnames":["L"],"suffixes":[]},{"propositions":["de"],"lastnames":["Vries"],"firstnames":["N"],"suffixes":[]},{"propositions":[],"lastnames":["Harding"],"firstnames":["J"],"suffixes":[]},{"propositions":[],"lastnames":["Gumbo"],"firstnames":["T"],"suffixes":[]},{"propositions":[],"lastnames":["Warren"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["Maartens"],"firstnames":["G"],"suffixes":[]},{"propositions":[],"lastnames":["Denti"],"firstnames":["P"],"suffixes":[]},{"propositions":[],"lastnames":["McIlleron"],"firstnames":["H"],"suffixes":[]}],"doi":"10.1128/AAC.01426-22","issn":"0066-4804","journal":"Antimicrobial Agents and Chemotherapy","keywords":"MDR-TB,efavirenz,moxifloxacin,multidrug resistance,original,pharmacometrics,population pharmacokinetics","mendeley-tags":"original","month":"feb","pages":"10.1128/aac.01426–22","pmid":"36744891","publisher":"American Society for Microbiology 1752 N St., N.W., Washington, DC","title":"Optimizing moxifloxacin dose in MDR-TB participants with or without efavirenz coadministration using population pharmacokinetic modeling","url":"https://journals.asm.org/doi/10.1128/aac.01426-22","year":"2023","bibtex":"@article{Chirehwa2023,\r\nabstract = {Moxifloxacin is included in some treatment regimens for drug-sensitive tuberculosis (TB) and multidrug-resistant TB (MDR-TB). Aiming to optimize dosing, we described moxifloxacin pharmacokinetic an...},\r\nauthor = {Chirehwa, M T and Resendiz-Galvan, J E and Court, R and {De Kock}, M and Wiesner, L and de Vries, N and Harding, J and Gumbo, T and Warren, R and Maartens, G and Denti, P and McIlleron, H},\r\ndoi = {10.1128/AAC.01426-22},\r\nissn = {0066-4804},\r\njournal = {Antimicrobial Agents and Chemotherapy},\r\nkeywords = {MDR-TB,efavirenz,moxifloxacin,multidrug resistance,original,pharmacometrics,population pharmacokinetics},\r\nmendeley-tags = {original},\r\nmonth = {feb},\r\npages = {10.1128/aac.01426--22},\r\npmid = {36744891},\r\npublisher = {American Society for Microbiology 1752 N St., N.W., Washington, DC},\r\ntitle = {{Optimizing moxifloxacin dose in MDR-TB participants with or without efavirenz coadministration using population pharmacokinetic modeling}},\r\nurl = {https://journals.asm.org/doi/10.1128/aac.01426-22},\r\nyear = {2023}\r\n}\r\n","author_short":["Chirehwa, M T","Resendiz-Galvan, J E","Court, R","De Kock, M","Wiesner, L","de Vries, N","Harding, J","Gumbo, T","Warren, R","Maartens, G","Denti, P","McIlleron, H"],"key":"Chirehwa2023","id":"Chirehwa2023","bibbaseid":"chirehwa-resendizgalvan-court-dekock-wiesner-devries-harding-gumbo-etal-optimizingmoxifloxacindoseinmdrtbparticipantswithorwithoutefavirenzcoadministrationusingpopulationpharmacokineticmodeling-2023","role":"author","urls":{"Paper":"https://journals.asm.org/doi/10.1128/aac.01426-22"},"keyword":["MDR-TB","efavirenz","moxifloxacin","multidrug resistance","original","pharmacometrics","population pharmacokinetics"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["mdr-tb","efavirenz","moxifloxacin","multidrug resistance","original","pharmacometrics","population pharmacokinetics"],"search_terms":["optimizing","moxifloxacin","dose","mdr","participants","without","efavirenz","coadministration","using","population","pharmacokinetic","modeling","chirehwa","resendiz-galvan","court","de kock","wiesner","de vries","harding","gumbo","warren","maartens","denti","mcilleron"],"title":"Optimizing moxifloxacin dose in MDR-TB participants with or without efavirenz coadministration using population pharmacokinetic modeling","year":2023}